(RTTNews) - OptiNose, Inc. (OPTN), a pharmaceutical company, on Wednesday that its net loss narrowed in the fourth quarter compared with the last year.
In the fourth quarter, net loss $0.36 million, narrower than $9.97 million last year.
Loss per share was $0.03 versus $1.33 in the prior year.
Two Analysts, on average, had expected the company to report loss of $0.84 per share. Analysts' estimates typically exclude special items.
Revenue increased 13 percent to $22.42 million from $19.87 million the previous year.
In the pre-market trading, OptiNose is 0.55% lesser at $9.17 on the Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
